nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclizine—Imatinib—hematologic cancer	0.522	1	CrCtD
Meclizine—Imatinib—Nilotinib—hematologic cancer	0.225	0.8	CrCrCtD
Meclizine—Buclizine—Imatinib—hematologic cancer	0.0562	0.2	CrCrCtD
Meclizine—CYP1A2—Anagrelide—hematologic cancer	0.0347	0.217	CbGbCtD
Meclizine—CYP1A2—Carmustine—hematologic cancer	0.0182	0.114	CbGbCtD
Meclizine—CYP1A2—Methoxsalen—hematologic cancer	0.0155	0.097	CbGbCtD
Meclizine—CYP1A2—Bortezomib—hematologic cancer	0.0148	0.0922	CbGbCtD
Meclizine—CYP1A2—Daunorubicin—hematologic cancer	0.0141	0.0882	CbGbCtD
Meclizine—CYP1A2—Alitretinoin—hematologic cancer	0.0138	0.0864	CbGbCtD
Meclizine—CYP1A2—Thalidomide—hematologic cancer	0.0129	0.0803	CbGbCtD
Meclizine—CYP1A2—Dacarbazine—hematologic cancer	0.0111	0.0691	CbGbCtD
Meclizine—CYP1A2—Imatinib—hematologic cancer	0.0108	0.0676	CbGbCtD
Meclizine—CYP1A2—Dasatinib—hematologic cancer	0.00868	0.0543	CbGbCtD
Meclizine—CYP1A2—Etoposide—hematologic cancer	0.00541	0.0338	CbGbCtD
Meclizine—Anaphylactoid reaction—Daunorubicin—hematologic cancer	0.000522	0.0165	CcSEcCtD
Meclizine—Dry mouth—Vorinostat—hematologic cancer	0.000374	0.0118	CcSEcCtD
Meclizine—Fatigue—Ruxolitinib—hematologic cancer	0.000373	0.0118	CcSEcCtD
Meclizine—Imatinib—ABL2—hematologic cancer	0.000363	0.181	CrCbGaD
Meclizine—Imatinib—LCK—hematologic cancer	0.000347	0.172	CrCbGaD
Meclizine—Drowsiness—Procarbazine—hematologic cancer	0.000327	0.0103	CcSEcCtD
Meclizine—Fatigue—Vorinostat—hematologic cancer	0.000316	0.00998	CcSEcCtD
Meclizine—Anaphylactic shock—Mechlorethamine—hematologic cancer	0.000314	0.00994	CcSEcCtD
Meclizine—Asthenia—Ruxolitinib—hematologic cancer	0.000311	0.00982	CcSEcCtD
Meclizine—Vision blurred—Nelarabine—hematologic cancer	0.000306	0.00968	CcSEcCtD
Meclizine—Vision blurred—Anagrelide—hematologic cancer	0.000285	0.00902	CcSEcCtD
Meclizine—Headache—Ruxolitinib—hematologic cancer	0.000271	0.00858	CcSEcCtD
Meclizine—Asthenia—Vorinostat—hematologic cancer	0.000263	0.0083	CcSEcCtD
Meclizine—Anaphylactoid reaction—Irinotecan—hematologic cancer	0.000255	0.00806	CcSEcCtD
Meclizine—Anaphylactoid reaction—Mitoxantrone—hematologic cancer	0.000255	0.00806	CcSEcCtD
Meclizine—Dry mouth—Daunorubicin—hematologic cancer	0.000253	0.00801	CcSEcCtD
Meclizine—Drowsiness—Hydroxyurea—hematologic cancer	0.000253	0.008	CcSEcCtD
Meclizine—Dry mouth—Anagrelide—hematologic cancer	0.000252	0.00797	CcSEcCtD
Meclizine—Anaphylactoid reaction—Gemcitabine—hematologic cancer	0.000248	0.00785	CcSEcCtD
Meclizine—Anaphylactic shock—Daunorubicin—hematologic cancer	0.000248	0.00785	CcSEcCtD
Meclizine—Anaphylactic shock—Idarubicin—hematologic cancer	0.000238	0.00753	CcSEcCtD
Meclizine—Vision blurred—Dasatinib—hematologic cancer	0.000236	0.00746	CcSEcCtD
Meclizine—Somnolence—Nelarabine—hematologic cancer	0.000236	0.00745	CcSEcCtD
Meclizine—Anaphylactoid reaction—Cisplatin—hematologic cancer	0.000231	0.00731	CcSEcCtD
Meclizine—Headache—Vorinostat—hematologic cancer	0.000229	0.00725	CcSEcCtD
Meclizine—Fatigue—Nelarabine—hematologic cancer	0.000229	0.00723	CcSEcCtD
Meclizine—Somnolence—Clofarabine—hematologic cancer	0.000221	0.00698	CcSEcCtD
Meclizine—Somnolence—Daunorubicin—hematologic cancer	0.000221	0.00698	CcSEcCtD
Meclizine—Somnolence—Anagrelide—hematologic cancer	0.00022	0.00694	CcSEcCtD
Meclizine—Somnolence—Pentostatin—hematologic cancer	0.00022	0.00694	CcSEcCtD
Meclizine—Dry mouth—Busulfan—hematologic cancer	0.000219	0.00693	CcSEcCtD
Meclizine—Vision blurred—Nilotinib—hematologic cancer	0.000218	0.00689	CcSEcCtD
Meclizine—Vision blurred—Imatinib—hematologic cancer	0.000217	0.00685	CcSEcCtD
Meclizine—Fatigue—Clofarabine—hematologic cancer	0.000214	0.00677	CcSEcCtD
Meclizine—Fatigue—Daunorubicin—hematologic cancer	0.000214	0.00677	CcSEcCtD
Meclizine—Fatigue—Anagrelide—hematologic cancer	0.000213	0.00674	CcSEcCtD
Meclizine—Fatigue—Pentostatin—hematologic cancer	0.000213	0.00674	CcSEcCtD
Meclizine—Drowsiness—Thalidomide—hematologic cancer	0.000213	0.00673	CcSEcCtD
Meclizine—Dry mouth—Procarbazine—hematologic cancer	0.000213	0.00672	CcSEcCtD
Meclizine—Anaphylactoid reaction—Etoposide—hematologic cancer	0.000212	0.0067	CcSEcCtD
Meclizine—Anaphylactoid reaction—Prednisolone—hematologic cancer	0.000209	0.00661	CcSEcCtD
Meclizine—Imatinib—CSF1R—hematologic cancer	0.000209	0.104	CrCbGaD
Meclizine—Dry mouth—Bexarotene—hematologic cancer	0.000208	0.00659	CcSEcCtD
Meclizine—Anaphylactic shock—Fludarabine—hematologic cancer	0.000204	0.00644	CcSEcCtD
Meclizine—Drowsiness—Alitretinoin—hematologic cancer	0.000203	0.0064	CcSEcCtD
Meclizine—Dry mouth—Nilotinib—hematologic cancer	0.000193	0.00609	CcSEcCtD
Meclizine—Anaphylactoid reaction—Triamcinolone—hematologic cancer	0.000192	0.00608	CcSEcCtD
Meclizine—Dry mouth—Imatinib—hematologic cancer	0.000191	0.00605	CcSEcCtD
Meclizine—Somnolence—Busulfan—hematologic cancer	0.000191	0.00604	CcSEcCtD
Meclizine—Asthenia—Nelarabine—hematologic cancer	0.00019	0.00602	CcSEcCtD
Meclizine—Drowsiness—Mitoxantrone—hematologic cancer	0.00019	0.00601	CcSEcCtD
Meclizine—Vision blurred—Lenalidomide—hematologic cancer	0.000189	0.00597	CcSEcCtD
Meclizine—Anaphylactic shock—Imatinib—hematologic cancer	0.000188	0.00593	CcSEcCtD
Meclizine—Somnolence—Procarbazine—hematologic cancer	0.000185	0.00586	CcSEcCtD
Meclizine—Fatigue—Busulfan—hematologic cancer	0.000185	0.00586	CcSEcCtD
Meclizine—Imatinib—PDGFRB—hematologic cancer	0.000182	0.0906	CrCbGaD
Meclizine—Somnolence—Bexarotene—hematologic cancer	0.000182	0.00574	CcSEcCtD
Meclizine—Somnolence—Dasatinib—hematologic cancer	0.000182	0.00574	CcSEcCtD
Meclizine—Fatigue—Procarbazine—hematologic cancer	0.00018	0.00568	CcSEcCtD
Meclizine—Asthenia—Clofarabine—hematologic cancer	0.000178	0.00563	CcSEcCtD
Meclizine—Asthenia—Daunorubicin—hematologic cancer	0.000178	0.00563	CcSEcCtD
Meclizine—Imatinib—PDGFRA—hematologic cancer	0.000178	0.0883	CrCbGaD
Meclizine—Asthenia—Anagrelide—hematologic cancer	0.000177	0.0056	CcSEcCtD
Meclizine—Asthenia—Pentostatin—hematologic cancer	0.000177	0.0056	CcSEcCtD
Meclizine—Fatigue—Bexarotene—hematologic cancer	0.000176	0.00557	CcSEcCtD
Meclizine—Fatigue—Dasatinib—hematologic cancer	0.000176	0.00557	CcSEcCtD
Meclizine—Fatigue—Fludarabine—hematologic cancer	0.000176	0.00555	CcSEcCtD
Meclizine—Anaphylactoid reaction—Dexamethasone—hematologic cancer	0.000174	0.00551	CcSEcCtD
Meclizine—Anaphylactoid reaction—Betamethasone—hematologic cancer	0.000174	0.00551	CcSEcCtD
Meclizine—Vision blurred—Bortezomib—hematologic cancer	0.000174	0.0055	CcSEcCtD
Meclizine—Anaphylactic shock—Melphalan—hematologic cancer	0.000168	0.00532	CcSEcCtD
Meclizine—Dry mouth—Lenalidomide—hematologic cancer	0.000167	0.00528	CcSEcCtD
Meclizine—Somnolence—Imatinib—hematologic cancer	0.000167	0.00527	CcSEcCtD
Meclizine—Fatigue—Chlorambucil—hematologic cancer	0.000166	0.00526	CcSEcCtD
Meclizine—Asthenia—Teniposide—hematologic cancer	0.000166	0.00526	CcSEcCtD
Meclizine—Headache—Nelarabine—hematologic cancer	0.000166	0.00525	CcSEcCtD
Meclizine—Somnolence—Cladribine—hematologic cancer	0.000164	0.00518	CcSEcCtD
Meclizine—Fatigue—Nilotinib—hematologic cancer	0.000163	0.00514	CcSEcCtD
Meclizine—Imatinib—ABL1—hematologic cancer	0.000162	0.0807	CrCbGaD
Meclizine—Headache—Methoxsalen—hematologic cancer	0.000162	0.00513	CcSEcCtD
Meclizine—Vision blurred—Thiotepa—hematologic cancer	0.000162	0.00512	CcSEcCtD
Meclizine—Fatigue—Imatinib—hematologic cancer	0.000162	0.00512	CcSEcCtD
Meclizine—Fatigue—Cladribine—hematologic cancer	0.000159	0.00503	CcSEcCtD
Meclizine—Vision blurred—Thalidomide—hematologic cancer	0.000157	0.00496	CcSEcCtD
Meclizine—Headache—Clofarabine—hematologic cancer	0.000156	0.00492	CcSEcCtD
Meclizine—Headache—Daunorubicin—hematologic cancer	0.000156	0.00492	CcSEcCtD
Meclizine—Headache—Anagrelide—hematologic cancer	0.000155	0.00489	CcSEcCtD
Meclizine—Headache—Pentostatin—hematologic cancer	0.000155	0.00489	CcSEcCtD
Meclizine—Asthenia—Busulfan—hematologic cancer	0.000154	0.00487	CcSEcCtD
Meclizine—Vision blurred—Carmustine—hematologic cancer	0.000151	0.00476	CcSEcCtD
Meclizine—Anaphylactic shock—Bortezomib—hematologic cancer	0.000151	0.00476	CcSEcCtD
Meclizine—Asthenia—Procarbazine—hematologic cancer	0.00015	0.00473	CcSEcCtD
Meclizine—Anaphylactic shock—Bleomycin—hematologic cancer	0.000149	0.00472	CcSEcCtD
Meclizine—Headache—Idarubicin—hematologic cancer	0.000149	0.00472	CcSEcCtD
Meclizine—Vision blurred—Alitretinoin—hematologic cancer	0.000149	0.00472	CcSEcCtD
Meclizine—Vision blurred—Ifosfamide—hematologic cancer	0.000147	0.00466	CcSEcCtD
Meclizine—Anaphylactic shock—Vinorelbine—hematologic cancer	0.000147	0.00465	CcSEcCtD
Meclizine—Asthenia—Bexarotene—hematologic cancer	0.000147	0.00463	CcSEcCtD
Meclizine—Asthenia—Dasatinib—hematologic cancer	0.000147	0.00463	CcSEcCtD
Meclizine—Asthenia—Fludarabine—hematologic cancer	0.000146	0.00462	CcSEcCtD
Meclizine—Somnolence—Lenalidomide—hematologic cancer	0.000145	0.0046	CcSEcCtD
Meclizine—Headache—Teniposide—hematologic cancer	0.000145	0.00459	CcSEcCtD
Meclizine—Fatigue—Melphalan—hematologic cancer	0.000145	0.00459	CcSEcCtD
Meclizine—Somnolence—Hydroxyurea—hematologic cancer	0.000143	0.00453	CcSEcCtD
Meclizine—Fatigue—Lenalidomide—hematologic cancer	0.000141	0.00446	CcSEcCtD
Meclizine—Vision blurred—Mitoxantrone—hematologic cancer	0.00014	0.00443	CcSEcCtD
Meclizine—Fatigue—Hydroxyurea—hematologic cancer	0.000139	0.0044	CcSEcCtD
Meclizine—Dry mouth—Thalidomide—hematologic cancer	0.000139	0.00438	CcSEcCtD
Meclizine—Asthenia—Chlorambucil—hematologic cancer	0.000138	0.00438	CcSEcCtD
Meclizine—Asthenia—Nilotinib—hematologic cancer	0.000135	0.00428	CcSEcCtD
Meclizine—Asthenia—Imatinib—hematologic cancer	0.000135	0.00426	CcSEcCtD
Meclizine—Headache—Busulfan—hematologic cancer	0.000135	0.00425	CcSEcCtD
Meclizine—Asthenia—Cladribine—hematologic cancer	0.000132	0.00418	CcSEcCtD
Meclizine—Dry mouth—Alitretinoin—hematologic cancer	0.000132	0.00417	CcSEcCtD
Meclizine—Headache—Procarbazine—hematologic cancer	0.000131	0.00413	CcSEcCtD
Meclizine—Imatinib—KIT—hematologic cancer	0.00013	0.0648	CrCbGaD
Meclizine—Fatigue—Bortezomib—hematologic cancer	0.00013	0.0041	CcSEcCtD
Meclizine—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000129	0.00408	CcSEcCtD
Meclizine—Headache—Dasatinib—hematologic cancer	0.000128	0.00405	CcSEcCtD
Meclizine—Headache—Bexarotene—hematologic cancer	0.000128	0.00405	CcSEcCtD
Meclizine—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000128	0.00404	CcSEcCtD
Meclizine—Headache—Fludarabine—hematologic cancer	0.000128	0.00403	CcSEcCtD
Meclizine—Vision blurred—Cisplatin—hematologic cancer	0.000127	0.00402	CcSEcCtD
Meclizine—Anaphylactoid reaction—Methotrexate—hematologic cancer	0.000127	0.00401	CcSEcCtD
Meclizine—Asthenia—Vinblastine—hematologic cancer	0.000127	0.00401	CcSEcCtD
Meclizine—Fatigue—Vinorelbine—hematologic cancer	0.000127	0.00401	CcSEcCtD
Meclizine—Imatinib—CA9—hematologic cancer	0.000125	0.0622	CrCbGaD
Meclizine—Somnolence—Thiotepa—hematologic cancer	0.000125	0.00395	CcSEcCtD
Meclizine—Anaphylactic shock—Vincristine—hematologic cancer	0.000124	0.00393	CcSEcCtD
Meclizine—Anaphylactic shock—Irinotecan—hematologic cancer	0.000121	0.00383	CcSEcCtD
Meclizine—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000121	0.00383	CcSEcCtD
Meclizine—Fatigue—Thiotepa—hematologic cancer	0.000121	0.00383	CcSEcCtD
Meclizine—Asthenia—Melphalan—hematologic cancer	0.000121	0.00382	CcSEcCtD
Meclizine—Somnolence—Thalidomide—hematologic cancer	0.000121	0.00382	CcSEcCtD
Meclizine—Anaphylactoid reaction—Epirubicin—hematologic cancer	0.000119	0.00376	CcSEcCtD
Meclizine—Headache—Nilotinib—hematologic cancer	0.000118	0.00374	CcSEcCtD
Meclizine—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000118	0.00373	CcSEcCtD
Meclizine—Headache—Imatinib—hematologic cancer	0.000118	0.00372	CcSEcCtD
Meclizine—Asthenia—Lenalidomide—hematologic cancer	0.000117	0.00371	CcSEcCtD
Meclizine—Fatigue—Thalidomide—hematologic cancer	0.000117	0.0037	CcSEcCtD
Meclizine—Somnolence—Carmustine—hematologic cancer	0.000116	0.00366	CcSEcCtD
Meclizine—Asthenia—Hydroxyurea—hematologic cancer	0.000116	0.00366	CcSEcCtD
Meclizine—Headache—Cladribine—hematologic cancer	0.000116	0.00365	CcSEcCtD
Meclizine—Vision blurred—Prednisolone—hematologic cancer	0.000115	0.00363	CcSEcCtD
Meclizine—Somnolence—Alitretinoin—hematologic cancer	0.000115	0.00363	CcSEcCtD
Meclizine—Somnolence—Ifosfamide—hematologic cancer	0.000114	0.00359	CcSEcCtD
Meclizine—Fatigue—Alitretinoin—hematologic cancer	0.000111	0.00352	CcSEcCtD
Meclizine—Headache—Vinblastine—hematologic cancer	0.000111	0.0035	CcSEcCtD
Meclizine—Fatigue—Ifosfamide—hematologic cancer	0.00011	0.00348	CcSEcCtD
Meclizine—Anaphylactic shock—Cisplatin—hematologic cancer	0.00011	0.00348	CcSEcCtD
Meclizine—Anaphylactoid reaction—Doxorubicin—hematologic cancer	0.00011	0.00348	CcSEcCtD
Meclizine—Asthenia—Bortezomib—hematologic cancer	0.000108	0.00341	CcSEcCtD
Meclizine—Somnolence—Mitoxantrone—hematologic cancer	0.000108	0.00341	CcSEcCtD
Meclizine—Somnolence—Irinotecan—hematologic cancer	0.000108	0.00341	CcSEcCtD
Meclizine—Fatigue—Vincristine—hematologic cancer	0.000107	0.00339	CcSEcCtD
Meclizine—Asthenia—Bleomycin—hematologic cancer	0.000107	0.00339	CcSEcCtD
Meclizine—Asthenia—Vinorelbine—hematologic cancer	0.000105	0.00333	CcSEcCtD
Meclizine—Somnolence—Gemcitabine—hematologic cancer	0.000105	0.00332	CcSEcCtD
Meclizine—Fatigue—Irinotecan—hematologic cancer	0.000105	0.0033	CcSEcCtD
Meclizine—Fatigue—Mitoxantrone—hematologic cancer	0.000105	0.0033	CcSEcCtD
Meclizine—Imatinib—SLC22A1—hematologic cancer	0.000103	0.0514	CrCbGaD
Meclizine—Headache—Lenalidomide—hematologic cancer	0.000102	0.00324	CcSEcCtD
Meclizine—Fatigue—Gemcitabine—hematologic cancer	0.000102	0.00322	CcSEcCtD
Meclizine—Headache—Hydroxyurea—hematologic cancer	0.000101	0.00319	CcSEcCtD
Meclizine—Anaphylactic shock—Etoposide—hematologic cancer	0.000101	0.00319	CcSEcCtD
Meclizine—Asthenia—Thiotepa—hematologic cancer	0.000101	0.00318	CcSEcCtD
Meclizine—Anaphylactic shock—Prednisolone—hematologic cancer	9.95e-05	0.00314	CcSEcCtD
Meclizine—Asthenia—Thalidomide—hematologic cancer	9.74e-05	0.00308	CcSEcCtD
Meclizine—Drowsiness—Methotrexate—hematologic cancer	9.47e-05	0.00299	CcSEcCtD
Meclizine—Headache—Bortezomib—hematologic cancer	9.43e-05	0.00298	CcSEcCtD
Meclizine—Asthenia—Carmustine—hematologic cancer	9.36e-05	0.00296	CcSEcCtD
Meclizine—Dry mouth—Triamcinolone—hematologic cancer	9.33e-05	0.00295	CcSEcCtD
Meclizine—Asthenia—Alitretinoin—hematologic cancer	9.27e-05	0.00293	CcSEcCtD
Meclizine—Headache—Vinorelbine—hematologic cancer	9.21e-05	0.00291	CcSEcCtD
Meclizine—Asthenia—Ifosfamide—hematologic cancer	9.16e-05	0.0029	CcSEcCtD
Meclizine—Anaphylactic shock—Triamcinolone—hematologic cancer	9.15e-05	0.00289	CcSEcCtD
Meclizine—Somnolence—Etoposide—hematologic cancer	8.96e-05	0.00283	CcSEcCtD
Meclizine—Asthenia—Vincristine—hematologic cancer	8.93e-05	0.00282	CcSEcCtD
Meclizine—Drowsiness—Epirubicin—hematologic cancer	8.86e-05	0.0028	CcSEcCtD
Meclizine—Headache—Thiotepa—hematologic cancer	8.79e-05	0.00278	CcSEcCtD
Meclizine—Asthenia—Mitoxantrone—hematologic cancer	8.7e-05	0.00275	CcSEcCtD
Meclizine—Asthenia—Irinotecan—hematologic cancer	8.7e-05	0.00275	CcSEcCtD
Meclizine—Fatigue—Etoposide—hematologic cancer	8.69e-05	0.00275	CcSEcCtD
Meclizine—Headache—Thalidomide—hematologic cancer	8.51e-05	0.00269	CcSEcCtD
Meclizine—Asthenia—Gemcitabine—hematologic cancer	8.47e-05	0.00268	CcSEcCtD
Meclizine—Vision blurred—Prednisone—hematologic cancer	8.35e-05	0.00264	CcSEcCtD
Meclizine—Anaphylactic shock—Dexamethasone—hematologic cancer	8.3e-05	0.00262	CcSEcCtD
Meclizine—Anaphylactic shock—Betamethasone—hematologic cancer	8.3e-05	0.00262	CcSEcCtD
Meclizine—Drowsiness—Doxorubicin—hematologic cancer	8.2e-05	0.00259	CcSEcCtD
Meclizine—Headache—Carmustine—hematologic cancer	8.17e-05	0.00258	CcSEcCtD
Meclizine—Headache—Alitretinoin—hematologic cancer	8.09e-05	0.00256	CcSEcCtD
Meclizine—Asthenia—Cisplatin—hematologic cancer	7.9e-05	0.0025	CcSEcCtD
Meclizine—Fatigue—Triamcinolone—hematologic cancer	7.89e-05	0.00249	CcSEcCtD
Meclizine—Headache—Vincristine—hematologic cancer	7.8e-05	0.00247	CcSEcCtD
Meclizine—Headache—Irinotecan—hematologic cancer	7.59e-05	0.0024	CcSEcCtD
Meclizine—Headache—Mitoxantrone—hematologic cancer	7.59e-05	0.0024	CcSEcCtD
Meclizine—Headache—Gemcitabine—hematologic cancer	7.4e-05	0.00234	CcSEcCtD
Meclizine—Asthenia—Etoposide—hematologic cancer	7.23e-05	0.00229	CcSEcCtD
Meclizine—Anaphylactic shock—Prednisone—hematologic cancer	7.23e-05	0.00228	CcSEcCtD
Meclizine—Imatinib—ABCG2—hematologic cancer	7.21e-05	0.0359	CrCbGaD
Meclizine—Fatigue—Dexamethasone—hematologic cancer	7.15e-05	0.00226	CcSEcCtD
Meclizine—Fatigue—Betamethasone—hematologic cancer	7.15e-05	0.00226	CcSEcCtD
Meclizine—Vision blurred—Methotrexate—hematologic cancer	6.97e-05	0.0022	CcSEcCtD
Meclizine—Asthenia—Triamcinolone—hematologic cancer	6.56e-05	0.00207	CcSEcCtD
Meclizine—Vision blurred—Epirubicin—hematologic cancer	6.53e-05	0.00206	CcSEcCtD
Meclizine—Headache—Etoposide—hematologic cancer	6.32e-05	0.002	CcSEcCtD
Meclizine—Fatigue—Prednisone—hematologic cancer	6.23e-05	0.00197	CcSEcCtD
Meclizine—Headache—Prednisolone—hematologic cancer	6.23e-05	0.00197	CcSEcCtD
Meclizine—Anaphylactic shock—Methotrexate—hematologic cancer	6.04e-05	0.00191	CcSEcCtD
Meclizine—Vision blurred—Doxorubicin—hematologic cancer	6.04e-05	0.00191	CcSEcCtD
Meclizine—Asthenia—Dexamethasone—hematologic cancer	5.95e-05	0.00188	CcSEcCtD
Meclizine—Asthenia—Betamethasone—hematologic cancer	5.95e-05	0.00188	CcSEcCtD
Meclizine—Dry mouth—Epirubicin—hematologic cancer	5.77e-05	0.00182	CcSEcCtD
Meclizine—Headache—Triamcinolone—hematologic cancer	5.73e-05	0.00181	CcSEcCtD
Meclizine—Anaphylactic shock—Epirubicin—hematologic cancer	5.65e-05	0.00179	CcSEcCtD
Meclizine—Somnolence—Methotrexate—hematologic cancer	5.37e-05	0.0017	CcSEcCtD
Meclizine—Dry mouth—Doxorubicin—hematologic cancer	5.34e-05	0.00169	CcSEcCtD
Meclizine—Anaphylactic shock—Doxorubicin—hematologic cancer	5.23e-05	0.00165	CcSEcCtD
Meclizine—Fatigue—Methotrexate—hematologic cancer	5.21e-05	0.00165	CcSEcCtD
Meclizine—Headache—Betamethasone—hematologic cancer	5.2e-05	0.00164	CcSEcCtD
Meclizine—Headache—Dexamethasone—hematologic cancer	5.2e-05	0.00164	CcSEcCtD
Meclizine—Asthenia—Prednisone—hematologic cancer	5.19e-05	0.00164	CcSEcCtD
Meclizine—Somnolence—Epirubicin—hematologic cancer	5.03e-05	0.00159	CcSEcCtD
Meclizine—Fatigue—Epirubicin—hematologic cancer	4.87e-05	0.00154	CcSEcCtD
Meclizine—Somnolence—Doxorubicin—hematologic cancer	4.65e-05	0.00147	CcSEcCtD
Meclizine—Headache—Prednisone—hematologic cancer	4.53e-05	0.00143	CcSEcCtD
Meclizine—Fatigue—Doxorubicin—hematologic cancer	4.51e-05	0.00143	CcSEcCtD
Meclizine—Asthenia—Methotrexate—hematologic cancer	4.33e-05	0.00137	CcSEcCtD
Meclizine—Asthenia—Epirubicin—hematologic cancer	4.06e-05	0.00128	CcSEcCtD
Meclizine—Headache—Methotrexate—hematologic cancer	3.78e-05	0.0012	CcSEcCtD
Meclizine—Asthenia—Doxorubicin—hematologic cancer	3.75e-05	0.00119	CcSEcCtD
Meclizine—Headache—Epirubicin—hematologic cancer	3.54e-05	0.00112	CcSEcCtD
Meclizine—Headache—Doxorubicin—hematologic cancer	3.28e-05	0.00104	CcSEcCtD
Meclizine—Imatinib—ALB—hematologic cancer	3.15e-05	0.0156	CrCbGaD
Meclizine—Imatinib—ABCB1—hematologic cancer	3e-05	0.0149	CrCbGaD
Meclizine—Azelastine—ABCB1—hematologic cancer	2.91e-05	0.0145	CrCbGaD
Meclizine—Nefazodone—ABCB1—hematologic cancer	2.61e-05	0.013	CrCbGaD
Meclizine—Loperamide—ABCB1—hematologic cancer	2.19e-05	0.0109	CrCbGaD
Meclizine—CYP1A2—Metabolism—PHYH—hematologic cancer	3.36e-06	0.0011	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	3.33e-06	0.00109	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ARHGEF12—hematologic cancer	3.29e-06	0.00108	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ADCY7—hematologic cancer	3.29e-06	0.00108	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PTHLH—hematologic cancer	3.28e-06	0.00108	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ARHGEF1—hematologic cancer	3.21e-06	0.00105	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PTGER4—hematologic cancer	3.19e-06	0.00105	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	3.17e-06	0.00104	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	3.14e-06	0.00103	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SMPD3—hematologic cancer	3.08e-06	0.00101	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	3.07e-06	0.00101	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CCL3—hematologic cancer	3.01e-06	0.000988	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PTHLH—hematologic cancer	2.98e-06	0.000977	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—hematologic cancer	2.94e-06	0.000965	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PTGER4—hematologic cancer	2.9e-06	0.000951	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCL17—hematologic cancer	2.88e-06	0.000945	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AGRN—hematologic cancer	2.88e-06	0.000945	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.87e-06	0.000942	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CXCR5—hematologic cancer	2.83e-06	0.000928	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—CXCR4—hematologic cancer	2.82e-06	0.000925	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—hematologic cancer	2.82e-06	0.000924	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.79e-06	0.000918	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LEF1—hematologic cancer	2.78e-06	0.000911	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GNA13—hematologic cancer	2.73e-06	0.000896	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—IL3—hematologic cancer	2.72e-06	0.000892	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—B3GAT1—hematologic cancer	2.69e-06	0.000883	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—DCK—hematologic cancer	2.69e-06	0.000883	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ASNS—hematologic cancer	2.69e-06	0.000883	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TIAM1—hematologic cancer	2.68e-06	0.000881	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—RASGRP1—hematologic cancer	2.63e-06	0.000863	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.63e-06	0.000863	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—CCL2—hematologic cancer	2.61e-06	0.000858	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—JAK3—hematologic cancer	2.6e-06	0.000855	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—PIK3CA—hematologic cancer	2.6e-06	0.000853	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CXCR4—hematologic cancer	2.56e-06	0.00084	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HDC—hematologic cancer	2.55e-06	0.000837	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—hematologic cancer	2.53e-06	0.000831	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCR7—hematologic cancer	2.5e-06	0.000819	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CXCL13—hematologic cancer	2.5e-06	0.000819	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IL3—hematologic cancer	2.47e-06	0.00081	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NCOR2—hematologic cancer	2.46e-06	0.000809	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL3RA—hematologic cancer	2.43e-06	0.000798	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CRKL—hematologic cancer	2.43e-06	0.000798	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—RASGRP1—hematologic cancer	2.39e-06	0.000784	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.38e-06	0.00078	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—GRB2—hematologic cancer	2.36e-06	0.000776	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—RGS2—hematologic cancer	2.35e-06	0.00077	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CDA—hematologic cancer	2.33e-06	0.000765	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—hematologic cancer	2.32e-06	0.000763	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CMA1—hematologic cancer	2.32e-06	0.000762	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TRIO—hematologic cancer	2.32e-06	0.000762	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TRH—hematologic cancer	2.32e-06	0.000762	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AGO2—hematologic cancer	2.27e-06	0.000745	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SPHK1—hematologic cancer	2.27e-06	0.000745	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HDAC9—hematologic cancer	2.25e-06	0.000738	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LPAR1—hematologic cancer	2.25e-06	0.000738	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PC—hematologic cancer	2.24e-06	0.000737	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—H3F3B—hematologic cancer	2.22e-06	0.00073	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC35B2—hematologic cancer	2.17e-06	0.000711	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GBA—hematologic cancer	2.17e-06	0.000711	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—hematologic cancer	2.15e-06	0.000706	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—GRB2—hematologic cancer	2.15e-06	0.000705	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—CSF2—hematologic cancer	2.11e-06	0.000693	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PDE4B—hematologic cancer	2.07e-06	0.000679	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CNR2—hematologic cancer	2.07e-06	0.000679	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	2.06e-06	0.000676	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FGF19—hematologic cancer	2.05e-06	0.000673	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PRKCG—hematologic cancer	2.04e-06	0.000669	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—JAK1—hematologic cancer	2.04e-06	0.000669	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—RAC2—hematologic cancer	2.03e-06	0.000668	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—DKK1—hematologic cancer	2.02e-06	0.000663	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—STAT5B—hematologic cancer	2e-06	0.000657	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MTAP—hematologic cancer	1.98e-06	0.000651	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADCY7—hematologic cancer	1.94e-06	0.000638	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CSF2—hematologic cancer	1.92e-06	0.00063	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—IL2RA—hematologic cancer	1.9e-06	0.000625	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—XIAP—hematologic cancer	1.89e-06	0.000621	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—JAK1—hematologic cancer	1.85e-06	0.000608	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PRKCG—hematologic cancer	1.85e-06	0.000608	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SMARCA4—hematologic cancer	1.84e-06	0.000605	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SH2B3—hematologic cancer	1.84e-06	0.000605	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GZMB—hematologic cancer	1.83e-06	0.000601	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CTNNA1—hematologic cancer	1.79e-06	0.000587	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EIF4EBP1—hematologic cancer	1.78e-06	0.000584	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HSPB1—hematologic cancer	1.78e-06	0.000584	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCL3—hematologic cancer	1.78e-06	0.000584	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—FHL2—hematologic cancer	1.77e-06	0.00058	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PTHLH—hematologic cancer	1.76e-06	0.000577	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SDC1—hematologic cancer	1.76e-06	0.000577	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AGRN—hematologic cancer	1.73e-06	0.000569	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IL2RA—hematologic cancer	1.73e-06	0.000568	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PTGER4—hematologic cancer	1.71e-06	0.000562	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LCK—hematologic cancer	1.7e-06	0.000559	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—H3F3A—hematologic cancer	1.67e-06	0.000548	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—IDH2—hematologic cancer	1.64e-06	0.000539	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HMMR—hematologic cancer	1.64e-06	0.000539	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PRKCZ—hematologic cancer	1.62e-06	0.000533	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3CG—hematologic cancer	1.59e-06	0.000521	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PARP1—hematologic cancer	1.57e-06	0.000514	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.55e-06	0.000508	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ARNTL—hematologic cancer	1.54e-06	0.000507	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FBXW7—hematologic cancer	1.54e-06	0.000506	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CXCR4—hematologic cancer	1.51e-06	0.000496	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HDAC2—hematologic cancer	1.51e-06	0.000496	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CA9—hematologic cancer	1.5e-06	0.000493	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ACP5—hematologic cancer	1.5e-06	0.000493	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NCOR2—hematologic cancer	1.48e-06	0.000487	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CBL—hematologic cancer	1.47e-06	0.000484	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL3—hematologic cancer	1.46e-06	0.000479	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3CG—hematologic cancer	1.44e-06	0.000473	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PTPN1—hematologic cancer	1.43e-06	0.000471	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PTPN11—hematologic cancer	1.42e-06	0.000465	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—IDH1—hematologic cancer	1.41e-06	0.000464	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—RASGRP1—hematologic cancer	1.41e-06	0.000463	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HSP90AA1—hematologic cancer	1.41e-06	0.000461	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SYK—hematologic cancer	1.41e-06	0.000461	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ABCC3—hematologic cancer	1.4e-06	0.000458	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTO1—hematologic cancer	1.4e-06	0.000458	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TXN—hematologic cancer	1.4e-06	0.000458	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	1.39e-06	0.000458	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CREB1—hematologic cancer	1.37e-06	0.00045	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SPHK1—hematologic cancer	1.37e-06	0.000449	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—STAT1—hematologic cancer	1.36e-06	0.000445	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CCL2—hematologic cancer	1.34e-06	0.00044	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IL6R—hematologic cancer	1.34e-06	0.000439	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	1.32e-06	0.000432	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	1.31e-06	0.000431	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	1.28e-06	0.00042	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	1.28e-06	0.000419	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CRABP1—hematologic cancer	1.28e-06	0.000419	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	1.27e-06	0.000418	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GRB2—hematologic cancer	1.27e-06	0.000416	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	1.27e-06	0.000416	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	1.26e-06	0.000415	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—KITLG—hematologic cancer	1.25e-06	0.000409	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ALOX5—hematologic cancer	1.24e-06	0.000409	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	1.22e-06	0.0004	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	1.22e-06	0.000399	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	1.21e-06	0.000397	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NUP98—hematologic cancer	1.21e-06	0.000396	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	1.2e-06	0.000393	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ADCY7—hematologic cancer	1.17e-06	0.000384	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NCOA3—hematologic cancer	1.17e-06	0.000384	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CD86—hematologic cancer	1.17e-06	0.000384	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	1.16e-06	0.000381	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NUP214—hematologic cancer	1.16e-06	0.000381	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HES1—hematologic cancer	1.15e-06	0.000378	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.15e-06	0.000378	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	1.15e-06	0.000376	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MTR—hematologic cancer	1.14e-06	0.000374	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ABCG2—hematologic cancer	1.14e-06	0.000374	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FGF1—hematologic cancer	1.13e-06	0.000372	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CSF2—hematologic cancer	1.13e-06	0.000372	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	1.12e-06	0.000367	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ENO2—hematologic cancer	1.12e-06	0.000367	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	1.12e-06	0.000366	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	1.11e-06	0.000366	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	1.1e-06	0.000362	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	1.1e-06	0.00036	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—JAK1—hematologic cancer	1.09e-06	0.000359	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	1.09e-06	0.000359	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTT1—hematologic cancer	1.08e-06	0.000355	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.07e-06	0.00035	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SDC1—hematologic cancer	1.06e-06	0.000347	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	1.02e-06	0.000335	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IL2—hematologic cancer	1.01e-06	0.000333	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.01e-06	0.000332	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TERT—hematologic cancer	1.01e-06	0.000332	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.98e-07	0.000328	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	9.86e-07	0.000324	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TSC2—hematologic cancer	9.63e-07	0.000316	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.55e-07	0.000313	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	9.27e-07	0.000304	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	9.18e-07	0.000301	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ESR1—hematologic cancer	9e-07	0.000295	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NQO1—hematologic cancer	9e-07	0.000295	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CD44—hematologic cancer	9e-07	0.000295	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FN1—hematologic cancer	8.89e-07	0.000292	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.81e-07	0.000289	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—BAD—hematologic cancer	8.79e-07	0.000288	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	8.79e-07	0.000288	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	8.7e-07	0.000286	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CD80—hematologic cancer	8.52e-07	0.00028	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYCS—hematologic cancer	8.51e-07	0.00028	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	8.51e-07	0.000279	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—KIT—hematologic cancer	8.51e-07	0.000279	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	8.51e-07	0.000279	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	8.46e-07	0.000278	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	8.36e-07	0.000274	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	8.15e-07	0.000268	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CREB1—hematologic cancer	8.1e-07	0.000266	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—BRAF—hematologic cancer	8e-07	0.000263	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCL2—hematologic cancer	7.92e-07	0.00026	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL6R—hematologic cancer	7.9e-07	0.000259	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	7.89e-07	0.000259	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.61e-07	0.00025	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	7.53e-07	0.000247	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTP1—hematologic cancer	7.51e-07	0.000246	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	7.48e-07	0.000246	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	7.41e-07	0.000243	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	7.32e-07	0.00024	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.26e-07	0.000238	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FGF2—hematologic cancer	7.16e-07	0.000235	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ABCB1—hematologic cancer	7.1e-07	0.000233	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	7.06e-07	0.000232	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTM1—hematologic cancer	6.9e-07	0.000226	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NCOR1—hematologic cancer	6.9e-07	0.000226	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—JAK2—hematologic cancer	6.86e-07	0.000225	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	6.73e-07	0.000221	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MDM2—hematologic cancer	6.7e-07	0.00022	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	6.52e-07	0.000214	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MTOR—hematologic cancer	6.52e-07	0.000214	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	6.22e-07	0.000204	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	6.12e-07	0.000201	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MTHFR—hematologic cancer	6.1e-07	0.0002	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	6.05e-07	0.000199	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CASP3—hematologic cancer	6e-07	0.000197	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL2—hematologic cancer	5.99e-07	0.000197	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IL6—hematologic cancer	5.96e-07	0.000196	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCND1—hematologic cancer	5.84e-07	0.000192	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—JUN—hematologic cancer	5.82e-07	0.000191	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	5.65e-07	0.000185	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PTEN—hematologic cancer	5.63e-07	0.000185	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	5.51e-07	0.000181	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	5.5e-07	0.00018	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EP300—hematologic cancer	5.37e-07	0.000176	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.37e-07	0.000176	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SRC—hematologic cancer	5.22e-07	0.000172	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	5.12e-07	0.000168	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	5.09e-07	0.000167	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—STAT3—hematologic cancer	5.04e-07	0.000165	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NRAS—hematologic cancer	5.03e-07	0.000165	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	4.81e-07	0.000158	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CREBBP—hematologic cancer	4.75e-07	0.000156	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MYC—hematologic cancer	4.68e-07	0.000154	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	4.67e-07	0.000153	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	4.5e-07	0.000148	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ALB—hematologic cancer	4.44e-07	0.000146	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—KRAS—hematologic cancer	4.33e-07	0.000142	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	4.25e-07	0.00014	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	3.97e-07	0.00013	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	3.92e-07	0.000129	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TP53—hematologic cancer	3.84e-07	0.000126	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HRAS—hematologic cancer	3.68e-07	0.000121	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL6—hematologic cancer	3.52e-07	0.000116	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PTEN—hematologic cancer	3.39e-07	0.000111	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AKT1—hematologic cancer	3.25e-07	0.000107	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—EP300—hematologic cancer	3.23e-07	0.000106	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.39e-07	7.85e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AKT1—hematologic cancer	1.95e-07	6.42e-05	CbGpPWpGaD
